BusinessXOMA Presented First Data from Novel Antibody Fragment to Address Severe Acute Hypoglycemia at the ENDO MeetingBy Nasdaq OMXApr 4, 2016, 1:00 PM UTC
BusinessMetabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR DiagnosticBy Nasdaq OMXMar 29, 2016, 2:00 PM UTC
BusinessWellDoc® Announces Strategic Collaboration With LifeScan to Deliver Best-in-Class Digital Health Solution for Patients Living With Type 2 DiabetesBy Nasdaq OMXMar 1, 2016, 1:00 PM UTC
BusinessWellDoc® Publishes Framework for Developing Digital Therapeutics Programs That Improve Chronic Disease OutcomesBy Nasdaq OMXFeb 24, 2016, 6:00 PM UTC
BusinessXeris Pharmaceuticals, Inc. to Present G-Pen Human Factors Study Results at 2016 ATTD MeetingBy Nasdaq OMXFeb 4, 2016, 3:22 PM UTC
BusinessXeris Pharmaceuticals Announces $41 Million Series C FinancingBy Nasdaq OMXJan 7, 2016, 3:25 PM UTC
